- Home
- HPE vs DXCM Comparison
HPE vs DXCM Comparison
Compare HPE & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HPE | DXCM |
|---|---|---|
| Founded | 1939 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.5B | 25.9B |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | HPE | DXCM |
|---|---|---|
| Price | $24.16 | $66.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 21 |
| Target Price | $26.13 | ★ $86.86 |
| AVG Volume (30 Days) | ★ 25.5M | 4.4M |
| Earning Date | 12-04-2025 | 02-12-2026 |
| Dividend Yield | ★ 2.36% | N/A |
| EPS Growth | N/A | ★ 7.75 |
| EPS | N/A | ★ 1.80 |
| Revenue | ★ $34,296,000,000.00 | $4,515,900,000.00 |
| Revenue This Year | $20.20 | $17.38 |
| Revenue Next Year | $5.84 | $12.76 |
| P/E Ratio | ★ N/A | $37.03 |
| Revenue Growth | 13.84 | ★ 14.21 |
| 52 Week Low | $11.97 | $54.11 |
| 52 Week High | $26.44 | $93.25 |
Technical Indicators
Market Signals| Indicator | HPE | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 54.39 | 54.97 |
| Support Level | $23.39 | $66.00 |
| Resistance Level | $24.80 | $68.18 |
| Average True Range (ATR) | 0.51 | 1.46 |
| MACD | -0.05 | -0.10 |
| Stochastic Oscillator | 54.42 | 36.98 |
Price Performance
Historical ComparisonAbout HPE Hewlett Packard Enterprise Company
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment; it also has a high-performance computing business. HPE's stated goal is to be a complete edge-to-cloud company. Its portfolio enables hybrid clouds and hyperconverged infrastructure.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.